Bifidobacterium bifidum Rosell-71
What does the research say about Bifidobacterium bifidum Rosell-71?
4 health outcomes synthesisedBifidobacterium bifidum Rosell-71 has been researched for 4 health outcomes, all related to mental health and cognitive function. The strongest evidence, based on 4 studies, supports a moderate beneficial effect on depressive symptoms in adults with psychiatric and cognitive disorders, though the evidence strength is rated as low due to study design limitations and potential publication bias. No consistent effective dose or formulation information is available across the research syntheses, as most studies evaluated the strain as part of multi-strain probiotic blends.
Strongest evidence: The outcome with the most studies (4) is improved depressive symptoms in adults with psychiatric and cognitive disorders. All 4 studies reported beneficial effects, with effect sizes ranging from small to moderate. However, evidence strength is rated low because conclusions are preliminary, the evidence base is small, and only 1 of the 4 studies reported a statistically significant finding.
Mixed or weaker evidence: Three outcomes—improved cognitive function, reduced depression symptoms, and improved mental health—have low or very low evidence strength, each based on 3 studies. For cognitive function, effect sizes are mixed (small to large), and only 1 of 3 studies reached statistical significance. For depression symptoms, all 3 studies showed moderate beneficial effects, with 2 of 3 reporting statistical significance. For mental health, all 3 studies reported small beneficial effects, but none were statistically significant.
Effective dose patterns: No effective dose, form, or duration data were consistently reported across any of the 4 outcomes. All studies evaluated probiotics or synbiotics broadly, not Bifidobacterium bifidum Rosell-71 in isolation, making dose attribution impossible.
Population insights: The only specific population identified is adults with psychiatric disorders (including depression) and cognitive disorders. General adult samples were also included in some studies. No cross-cutting insights about specific subpopulations (e.g., elderly or deficient groups) emerged from the syntheses.
Notable caveats: The evidence base is very small (3–4 studies per outcome) and consists entirely of reviews, not direct clinical trials of the specific strain. Publication bias is likely, as null results are less likely to be published. Most studies used multi-strain formulations, so benefits cannot be uniquely attributed to this strain.
Frequently asked
What is Bifidobacterium bifidum Rosell-71 good for according to research?
Research on Bifidobacterium bifidum Rosell-71 has focused on mental health, specifically depressive symptoms, depression, cognitive function, and general mental health. All 4 outcomes show some beneficial effects across 3–4 studies each, but the evidence strength is low due to small study numbers, reliance on review articles rather than direct trials, and potential publication bias.What dose of Bifidobacterium bifidum Rosell-71 is typically used in studies?
No consistent dose, form, or duration data were reported across any of the 4 syntheses. All studies evaluated the strain as part of probiotic mixtures or synbiotics, making it impossible to determine a specific effective dose for this strain alone.Who benefits most from Bifidobacterium bifidum Rosell-71?
The only specific population identified in the research is adults with psychiatric disorders (including depression) and cognitive disorders. For depressive symptoms, evidence comes from studies of adults with psychiatric and cognitive disorders. For cognitive function, no specific population was reported across the 3 studies.Are there caveats or limitations in the research on Bifidobacterium bifidum Rosell-71?
Yes, major caveats include small study numbers (3–4 studies per outcome), evidence derived entirely from review articles (not direct clinical trials of the specific strain), and a high likelihood of publication bias since null results are rarely published. Additionally, benefits cannot be uniquely attributed to this strain as it was studied only as part of multi-strain formulations.Does Bifidobacterium bifidum Rosell-71 help with depressive symptoms?
Four studies report beneficial effects on depressive symptoms in adults with psychiatric and cognitive disorders, with effect sizes ranging from small to moderate. However, only 1 of 4 studies reported a statistically significant finding, and the evidence strength is low, so results should be considered preliminary.Does Bifidobacterium bifidum Rosell-71 improve cognitive function?
Three studies showed beneficial effects on cognitive function, but only 1 reached statistical significance (a meta-analysis reporting a large effect). The evidence base is very small and indirect, as studies evaluated probiotics generally rather than this specific strain, so findings are uncertain.
- Low evidenceImproved Depressive Symptoms
- Low evidenceReduced Depression Symptoms
- Low evidenceImproved Cognitive Function
- Very low evidenceImproved Mental Health
- Improved Gastrointestinal Symptoms
- Improved Gut Microbiota Balance
- Improved Liver Function
- Reduced Total Infections
- Reduced Neuroinflammation
- Reduced Anxiety